Displaying drugs 76 - 100 of 403 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Capromab pendetide | Not Available |  | A monoclonal anti-prostate specific membrane antigen antibody used in imaging kits to target radioactive agents to malignant prostate tissue. | Indium (111In) Compounds |
| Casirivimab | Not Available |  | Part of an investigational recombinant monoclonal antibody cocktail used to treat mild to moderate COVID-19. | Antiviral monoclonal antibodies |
| Catridecacog | Not Available |  | A recombinant FXIII subunit‐A molecule evaluated for clotting factor replacement therapy in congenital FXIII deficiency. | Blood Coagulation Factors |
| Catumaxomab | 150511.0 |  | For use in the management of malignant ascites tumours via intraperitoneal infusion where standard therapy is not available or feasible [FDA Label]. | Gastrointestinal Agents |
| Cemiplimab | 146000.0 C6380H9808N1688O2000S44 | | A programmed death receptor-1 blocking antibody used to treat cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer. | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Cenegermin | 13226.0 C583H908N166O173S8 | | A recombinant human nerve growth factor used to treat neurotrophic keratitis. | Recombinant Human Nerve Growth Factor |
| Cerliponase alfa | 59.0 | | An enzyme replacement therapy used to treat neuronal ceroid lipofuscinosis type 2 (CLN2) disease, also known as tripeptidyl peptidase 1 (TPP1) deficiency. | Enzymes / Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase |
| Certolizumab pegol | 91000.0 C2115H3252N556O673S16 |  | A tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Cetuximab | 145781.6 C6484H10042N1732O2023S36 |  | An endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck. | Antibodies, Monoclonal / EGFR (Epidermal Growth Factor Receptor) inhibitors |
| Choriogonadotropin alfa | 25719.7 C1105H1770N318O336S26 |  | A recombinant form of human chorionic gonadotropin used to treat female infertility by inducing ovulation. | Gonadotropins |
| Chorionic Gonadotropin (Human) | Not Available |  | A naturally-occurring hormone produced during human placenta used for the treatment of prepubertal cryptorchidism and hypogonadotropic hypogonadism in selected males, and induction of pregnancy in selected infertile women. | Biological Products / Chorionic Gonadotropin / Fertility Agents, Female / Gonadotropins / Gonadotropins, Pituitary / Placental Hormones / Pregnancy Proteins / Reproductive Control Agents |
| Chymopapain | 27000.0 |  | Chymopapain is indicated for the development of chemonucleolysis which is used for the digestion of the nucleus pulposus in patients with disc herniation confirmed by myelography. A disc herniation occurs... | Enzymes |
| Cilgavimab | 152000.0 C6626H10218N1750O2078S44 | | An extended half-life recombinant monoclonal IgG1κ antibody directed against the SARS-CoV-2 S protein for COVID-19 prophylaxis in individuals unable to undergo COVID-19 immunization. | Antiviral monoclonal antibodies |
| Cipaglucosidase alfa | 99400.0 C4489H6796N1197O1298S32 | | A recombinant human acid alpha-glucosidase used to treat late-onset Pompe disease in adults. | Enzymes |
| Coagulation Factor IX (Recombinant) | 46548.2 C2041H3136N558O641S25 |  | A form of recombinant human coagulation Factor IX used to treat hemophilia B. | Blood Coagulation Factors |
| Coagulation Factor IX Human | 46548.2 C2041H3136N558O641S25 |  | A coagulation factor used to treat hemophilia B or factor IX hemophilia. | Blood Coagulation Factors / Enzyme Precursors / Factor IX |
| Coagulation factor VII human | Not Available | | A coagulation factor used to treat bleeding disorders such as hemophilia and Glanzmann's thrombasthenia. | Blood Coagulation Factors / Enzyme Precursors |
| Coagulation factor VIIa Recombinant Human | 45079.1 C1972H3076N560O597S28 |  | A form of recombinant human coagulation Factor VII used to treat hemophilia A and B. | Blood Coagulation Factors / Factor VII / Factor VIIa, antagonists & inhibitors / Serine Endopeptidases |
| Coagulation factor X human | 59000.0 |  | A coagulation factor used to treat Factor X deficiency to control bleeding. | Blood Coagulation Factors / Enzyme Precursors / Factor X / Factor X, agonists |
| Collagenase clostridium histolyticum | 112023.2 C5028H7666N1300O1564S21 |  | A collagenase enzyme used to promote debridement of necrotic tissue in burns and skin ulcers as well as to treat Dupuytren's contracture and Peyronie's disease. | Peptide Hydrolases |
| Conestat alfa | 67000.0 |  | A recombinant C1INH used for the treatment of acute attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency in adults. | Drugs Used in Hereditary Angioedema |
| Coral snake (micrurus fulvius) immune globulin antivenin (equine) | Not Available | | A mixture of antibodies used to treat venomous snake bites from Micrurus fulvius (North American Coral Snake). | Antivenins |
| Corifollitropin alfa | 25398.0389 | | A FSH analogue indicated for Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program. | Gonadotropins |
| Corticorelin ovine triflutate | Not Available | | A synthetic corticotropin-releasing hormone used for diagnostic purposes in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome. | Tests for Pituitary Function |
| Corticotropin | 4541.0658 C207H308N56O58S | | A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency. | Adrenocorticotropic Hormone / Hormones / Melanocortins |
Displaying drugs 76 - 100 of 403 in total